Cargando…

NK cells encapsulated in micro/macropore-forming hydrogels via 3D bioprinting for tumor immunotherapy

BACKGROUND: Patients face a serious threat if a solid tumor leaves behind partial residuals or cannot be completely removed after surgical resection. Immunotherapy has attracted attention as a method to prevent this condition. However, the conventional immunotherapy method targeting solid tumors, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Dahong, Jo, Seona, Lee, Dongjin, Kim, Seok-Min, Seok, Ji Min, Yeo, Seon Ju, Lee, Jun Hee, Lee, Jae Jong, Lee, Kangwon, Kim, Tae-Don, Park, Su A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286468/
https://www.ncbi.nlm.nih.gov/pubmed/37349810
http://dx.doi.org/10.1186/s40824-023-00403-9
_version_ 1785061756361506816
author Kim, Dahong
Jo, Seona
Lee, Dongjin
Kim, Seok-Min
Seok, Ji Min
Yeo, Seon Ju
Lee, Jun Hee
Lee, Jae Jong
Lee, Kangwon
Kim, Tae-Don
Park, Su A
author_facet Kim, Dahong
Jo, Seona
Lee, Dongjin
Kim, Seok-Min
Seok, Ji Min
Yeo, Seon Ju
Lee, Jun Hee
Lee, Jae Jong
Lee, Kangwon
Kim, Tae-Don
Park, Su A
author_sort Kim, Dahong
collection PubMed
description BACKGROUND: Patients face a serious threat if a solid tumor leaves behind partial residuals or cannot be completely removed after surgical resection. Immunotherapy has attracted attention as a method to prevent this condition. However, the conventional immunotherapy method targeting solid tumors, that is, intravenous injection, has limitations in homing in on the tumor and in vivo expansion and has not shown effective clinical results. METHOD: To overcome these limitations, NK cells (Natural killer cells) were encapsulated in micro/macropore-forming hydrogels using 3D bioprinting to target solid tumors. Sodium alginate and gelatin were used to prepare micro-macroporous hydrogels. The gelatin contained in the alginate hydrogel was removed because of the thermal sensitivity of the gelatin, which can generate interconnected micropores where the gelatin was released. Therefore, macropores can be formed through bioprinting and micropores can be formed using thermally sensitive gelatin to make macroporous hydrogels. RESULTS: It was confirmed that intentionally formed micropores could help NK cells to aggregate easily, which enhances cell viability, lysis activity, and cytokine release. Macropores can be formed using 3D bioprinting, which enables NK cells to receive the essential elements. We also characterized the functionality of NK 92 and zEGFR-CAR-NK cells in the pore-forming hydrogel. The antitumor effects on leukemia and solid tumors were investigated using an in vitro model. CONCLUSION: We demonstrated that the hydrogel encapsulating NK cells created an appropriate micro–macro environment for clinical applications of NK cell therapy for both leukemia and solid tumors via 3D bioprinting. 3D bioprinting makes macro-scale clinical applications possible, and the automatic process shows potential for development as an off-the-shelf immunotherapy product. This immunotherapy system could provide a clinical option for preventing tumor relapse and metastasis after tumor resection. GRAPHICAL ABSTRACT: Micro/macropore-forming hydrogel with NK cells fabricated by 3D bioprinting and implanted into the tumor site. [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40824-023-00403-9.
format Online
Article
Text
id pubmed-10286468
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102864682023-06-23 NK cells encapsulated in micro/macropore-forming hydrogels via 3D bioprinting for tumor immunotherapy Kim, Dahong Jo, Seona Lee, Dongjin Kim, Seok-Min Seok, Ji Min Yeo, Seon Ju Lee, Jun Hee Lee, Jae Jong Lee, Kangwon Kim, Tae-Don Park, Su A Biomater Res Research Article BACKGROUND: Patients face a serious threat if a solid tumor leaves behind partial residuals or cannot be completely removed after surgical resection. Immunotherapy has attracted attention as a method to prevent this condition. However, the conventional immunotherapy method targeting solid tumors, that is, intravenous injection, has limitations in homing in on the tumor and in vivo expansion and has not shown effective clinical results. METHOD: To overcome these limitations, NK cells (Natural killer cells) were encapsulated in micro/macropore-forming hydrogels using 3D bioprinting to target solid tumors. Sodium alginate and gelatin were used to prepare micro-macroporous hydrogels. The gelatin contained in the alginate hydrogel was removed because of the thermal sensitivity of the gelatin, which can generate interconnected micropores where the gelatin was released. Therefore, macropores can be formed through bioprinting and micropores can be formed using thermally sensitive gelatin to make macroporous hydrogels. RESULTS: It was confirmed that intentionally formed micropores could help NK cells to aggregate easily, which enhances cell viability, lysis activity, and cytokine release. Macropores can be formed using 3D bioprinting, which enables NK cells to receive the essential elements. We also characterized the functionality of NK 92 and zEGFR-CAR-NK cells in the pore-forming hydrogel. The antitumor effects on leukemia and solid tumors were investigated using an in vitro model. CONCLUSION: We demonstrated that the hydrogel encapsulating NK cells created an appropriate micro–macro environment for clinical applications of NK cell therapy for both leukemia and solid tumors via 3D bioprinting. 3D bioprinting makes macro-scale clinical applications possible, and the automatic process shows potential for development as an off-the-shelf immunotherapy product. This immunotherapy system could provide a clinical option for preventing tumor relapse and metastasis after tumor resection. GRAPHICAL ABSTRACT: Micro/macropore-forming hydrogel with NK cells fabricated by 3D bioprinting and implanted into the tumor site. [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40824-023-00403-9. BioMed Central 2023-06-22 /pmc/articles/PMC10286468/ /pubmed/37349810 http://dx.doi.org/10.1186/s40824-023-00403-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Kim, Dahong
Jo, Seona
Lee, Dongjin
Kim, Seok-Min
Seok, Ji Min
Yeo, Seon Ju
Lee, Jun Hee
Lee, Jae Jong
Lee, Kangwon
Kim, Tae-Don
Park, Su A
NK cells encapsulated in micro/macropore-forming hydrogels via 3D bioprinting for tumor immunotherapy
title NK cells encapsulated in micro/macropore-forming hydrogels via 3D bioprinting for tumor immunotherapy
title_full NK cells encapsulated in micro/macropore-forming hydrogels via 3D bioprinting for tumor immunotherapy
title_fullStr NK cells encapsulated in micro/macropore-forming hydrogels via 3D bioprinting for tumor immunotherapy
title_full_unstemmed NK cells encapsulated in micro/macropore-forming hydrogels via 3D bioprinting for tumor immunotherapy
title_short NK cells encapsulated in micro/macropore-forming hydrogels via 3D bioprinting for tumor immunotherapy
title_sort nk cells encapsulated in micro/macropore-forming hydrogels via 3d bioprinting for tumor immunotherapy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286468/
https://www.ncbi.nlm.nih.gov/pubmed/37349810
http://dx.doi.org/10.1186/s40824-023-00403-9
work_keys_str_mv AT kimdahong nkcellsencapsulatedinmicromacroporeforminghydrogelsvia3dbioprintingfortumorimmunotherapy
AT joseona nkcellsencapsulatedinmicromacroporeforminghydrogelsvia3dbioprintingfortumorimmunotherapy
AT leedongjin nkcellsencapsulatedinmicromacroporeforminghydrogelsvia3dbioprintingfortumorimmunotherapy
AT kimseokmin nkcellsencapsulatedinmicromacroporeforminghydrogelsvia3dbioprintingfortumorimmunotherapy
AT seokjimin nkcellsencapsulatedinmicromacroporeforminghydrogelsvia3dbioprintingfortumorimmunotherapy
AT yeoseonju nkcellsencapsulatedinmicromacroporeforminghydrogelsvia3dbioprintingfortumorimmunotherapy
AT leejunhee nkcellsencapsulatedinmicromacroporeforminghydrogelsvia3dbioprintingfortumorimmunotherapy
AT leejaejong nkcellsencapsulatedinmicromacroporeforminghydrogelsvia3dbioprintingfortumorimmunotherapy
AT leekangwon nkcellsencapsulatedinmicromacroporeforminghydrogelsvia3dbioprintingfortumorimmunotherapy
AT kimtaedon nkcellsencapsulatedinmicromacroporeforminghydrogelsvia3dbioprintingfortumorimmunotherapy
AT parksua nkcellsencapsulatedinmicromacroporeforminghydrogelsvia3dbioprintingfortumorimmunotherapy